These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12918215)

  • 21. [2-week efficacy and tolerability of flupirtine MR and diclofenac in patients with acute low/back pain--results of a post-hoc subgroup analysis of patient-level data from four non-interventional studies].
    Uberall MA; Essner U; Müller-Schwefe GH
    MMW Fortschr Med; 2013 Dec; 155 Suppl 4():115-23. PubMed ID: 24934065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flupirtine: the first Italian experience.
    Ceccarelli G; Ciampini M; Frontespezi S
    Postgrad Med J; 1987; 63 Suppl 3():105-8. PubMed ID: 3328851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and tolerability of ready-to-use intravenous paracetamol solution as monotherapy or as an adjunct analgesic therapy for postoperative pain in patients undergoing elective ambulatory surgery: open, prospective study.
    Göröcs TS; Lambert M; Rinne T; Krekler M; Modell S
    Int J Clin Pract; 2009 Jan; 63(1):112-20. PubMed ID: 19125998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicenter, open-label, prospective evaluation of the conversion from previous opioid analgesics to extended-release hydromorphone hydrochloride administered every 24 hours to patients with persistent moderate to severe pain.
    Weinstein SM; Shi M; Buckley BJ; Kwarcinski MA
    Clin Ther; 2006 Jan; 28(1):86-98. PubMed ID: 16490582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience with flupirtine in the U.S.
    McMahon FG; Arndt WF; Newton JJ; Montgomery PA; Perhach JL
    Postgrad Med J; 1987; 63 Suppl 3():81-5. PubMed ID: 3328854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oxymorphone extended release for the treatment of chronic low back pain: a retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use.
    Peniston JH; Gould E
    Clin Ther; 2009 Feb; 31(2):347-59. PubMed ID: 19302907
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
    Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
    Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of flupirtine in treatment of tinnitus.
    Salembier L; De Ridder D; Van de Heyning PH
    Acta Otolaryngol Suppl; 2006 Dec; (556):93-5. PubMed ID: 17114151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and pharmacodynamic properties of tramadol IR and SR in elderly patients: a prospective, age-group-controlled study.
    Likar R; Wittels M; Molnar M; Kager I; Ziervogel G; Sittl R
    Clin Ther; 2006 Dec; 28(12):2022-39. PubMed ID: 17296459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of intranasal fentanyl spray 50 to 200 microg for breakthrough pain in patients with cancer: a phase III, multinational, randomized, double-blind, placebo-controlled, crossover trial with a 10-month, open-label extension treatment period.
    Kress HG; Orońska A; Kaczmarek Z; Kaasa S; Colberg T; Nolte T
    Clin Ther; 2009 Jun; 31(6):1177-91. PubMed ID: 19695386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain.
    Nicholson B; Ross E; Sasaki J; Weil A
    Curr Med Res Opin; 2006 Aug; 22(8):1503-14. PubMed ID: 16870075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of percutaneous sacroplasty for painful osteoporotic sacral insufficiency fractures: a prospective, multicenter trial.
    Frey ME; DePalma MJ; Cifu DX; Bhagia SM; Daitch JS
    Spine (Phila Pa 1976); 2007 Jul; 32(15):1635-40. PubMed ID: 17621211
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: an 18-month, multicenter, open-label, prospective study.
    Adachi JD; Hanley DA; Lorraine JK; Yu M
    Clin Ther; 2007 Sep; 29(9):2055-67. PubMed ID: 18035204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dextromethorphan and quinidine in adult patients with uncontrolled painful diabetic peripheral neuropathy: a 29-day, multicenter, open-label, dose-escalation study.
    Thisted RA; Klaff L; Schwartz SL; Wymer JP; Culligan NW; Gerard G; Pope LE; Berg JE
    Clin Ther; 2006 Oct; 28(10):1607-18. PubMed ID: 17157116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
    Simpson DM; Messina J; Xie F; Hale M
    Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of painful vertebral fractures by kyphoplasty in patients with primary osteoporosis: a prospective nonrandomized controlled study.
    Kasperk C; Hillmeier J; Nöldge G; Grafe IA; Dafonseca K; Raupp D; Bardenheuer H; Libicher M; Liegibel UM; Sommer U; Hilscher U; Pyerin W; Vetter M; Meinzer HP; Meeder PJ; Taylor RS; Nawroth P
    J Bone Miner Res; 2005 Apr; 20(4):604-12. PubMed ID: 15765179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A 2-week, multicenter, randomized, double-blind, placebo-controlled, dose-ranging, phase III trial comparing the efficacy of oxymorphone extended release and placebo in adults with pain associated with osteoarthritis of the hip or knee.
    Kivitz A; Ma C; Ahdieh H; Galer BS
    Clin Ther; 2006 Mar; 28(3):352-64. PubMed ID: 16750450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duloxetine for the treatment of major depressive disorder: safety and tolerability associated with dose escalation.
    Wohlreich MM; Mallinckrodt CH; Prakash A; Watkin JG; Carter WP
    Depress Anxiety; 2007; 24(1):41-52. PubMed ID: 16845641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An open-label study of a second course of hylan G-F 20 for the treatment of pain associated with knee osteoarthritis.
    Waddell DD; Cefalu CA; Bricker DC
    Curr Med Res Opin; 2003; 19(6):499-507. PubMed ID: 14594522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Balloon kyphoplasty for vertebral compression fractures in solid organ transplant recipients: results of treatment and comparison with primary osteoporotic vertebral compression fractures.
    Deen HG; Aranda-Michel J; Reimer R; Miller DA; Putzke JD
    Spine J; 2006; 6(5):494-9. PubMed ID: 16934717
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.